These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 6134539)

  • 1. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia.
    Foldes FF; Nagashima H; Boros M; Tassonyi E; Fitzal S; Agoston S
    Br J Anaesth; 1983; 55 Suppl 1():97S-103S. PubMed ID: 6190489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxants.
    Fisher DM; Rosen JI
    Anesthesiology; 1986 Sep; 65(3):286-91. PubMed ID: 2875680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrical and mechanical train-of-four responses during depolarizing and nondepolarizing neuromuscular blockade.
    Weber S; Muravchick S
    Anesth Analg; 1986 Jul; 65(7):771-6. PubMed ID: 2872838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of the dose-response and recovery time course of vecuronium and atracurium in anesthetized chinese adult patients.
    Xue FS; Li P; Liao X; Li CW; Xu YC; Liu Y; Liu KP; Sun HT
    Acta Anaesthesiol Taiwan; 2007 Mar; 45(1):9-14. PubMed ID: 17424753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of atracurium, vecuronium (Org NC 45) and pancuronium.
    Gramstad L; Lilleaasen P; Minsaas B
    Br J Anaesth; 1983; 55 Suppl 1():95S-96S. PubMed ID: 6134541
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical comparison of atracurium and vecuronium (Org NC 45).
    Robertson EN; Booij LH; Fragen RJ; Crul JF
    Br J Anaesth; 1983 Feb; 55(2):125-9. PubMed ID: 6131682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular block: atracurium and vecuronium compared and combined.
    Black TE; Healy TE; Pugh ND; Kay B; Harper NJ; Petts HV; Sivalingham T
    Eur J Anaesthesiol; 1985 Mar; 2(1):29-37. PubMed ID: 2862032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetanic fade following administration of nondepolarizing neuromuscular blocking drugs.
    Gibson FM; Mirakhur RK
    Anesth Analg; 1989 Jun; 68(6):759-62. PubMed ID: 2567584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant.
    Basta SJ; Ali HH; Savarese JJ; Sunder N; Gionfriddo M; Cloutier G; Lineberry C; Cato AE
    Anesth Analg; 1982 Sep; 61(9):723-9. PubMed ID: 6213181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1985 Nov; 57(11):1052-9. PubMed ID: 2864943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting train-of-four fade.
    Pearce AC; Casson WR; Jones RM
    Br J Anaesth; 1985 Jun; 57(6):602-6. PubMed ID: 2860913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans.
    Rimaniol JM; Dhonneur G; Sperry L; Duvaldestin P
    Anesth Analg; 1996 Oct; 83(4):808-13. PubMed ID: 8831326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of vecuronium, atracurium and pancuronium in divided doses: effect on onset and duration of action.
    Brady MM; Mirakhur RK; Clarke RS
    Eur J Anaesthesiol; 1988 Jul; 5(4):243-9. PubMed ID: 2904367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the onset time, duration of action, and fade characteristics of atracurium and vecuronium.
    Haines M
    AANA J; 1993 Dec; 61(6):592-6. PubMed ID: 7903505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia.
    Nathan N; Bonada G; Feiss P
    Acta Anaesthesiol Belg; 1996; 47(4):187-93. PubMed ID: 9093646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular and cardiovascular effects of atracurium during nitrous oxide-fentanyl and nitrous oxide-isoflurane anaesthesia.
    Rupp SM; Fahey MR; Miller RD
    Br J Anaesth; 1983; 55 Suppl 1():67S-70S. PubMed ID: 6688020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset time and duration of action for atracurium, Org NC45 and pancuronium.
    Gramstad L; Lilleaasen P; Minsaas B
    Br J Anaesth; 1982 Aug; 54(8):827-30. PubMed ID: 6125161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative clinical studies on vecuronium, atracurium and pancuronium in older patients].
    Schaer H; Baasch K; Nassehi R
    Anaesthesist; 1984 Nov; 33(11):543-7. PubMed ID: 6151366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.